PROLIDASE LEVEL IN CORONARY ARTERY DISEASE AND ISCHEMIC MITRAL VALVE INSUFFICIENCY

Authors : Vedat AĞRIÇ, Mustafa GÖZ, Reşat DİKME, Mahmut PADAK, Mehmet Salih AYDIN, Nazım KANKILIÇ, Bişar AMAÇ

Pages : 1499-1506

Doi:10.33715/inonusaglik.1163401

View : 46 | Download : 37

Publication Date : 2023-06-10

Article Type : Research Paper

Abstract :Plasma prolidase levels change as a determining factor for coronary artery disease and heart valve insufficiency. The aim of this study is to compare plasma prolidase levels in two groups with or without mitral regurgitation who underwent coronary artery bypass surgery insert ignore into journalissuearticles values(CABS);. For this purpose, 45 patients who underwent CABS were included in the study; patients without mitral valve insufficiency who underwent CABS insert ignore into journalissuearticles values(25 patients); Group 1, patients with mitral valve insufficiency who underwent CABS insert ignore into journalissuearticles values(20 patients); Group 2. Venous blood was taken from all patients before and after CABS and their prolidase levels were measured. Preoperative and postoperative serum prolidase levels in group 1 were 1038.2 and 1289.43 U/L, respectively. In group 2, preoperative and postoperative serum prolidase levels were 1084.07 and 1337.74 U/L, respectively. A significant difference was found between preoperative and postoperative plasma prolidase levels of Group 1 and Group 2 included in the study insert ignore into journalissuearticles values(p<0.05);. Plasma prolidase level was high in both groups. However, pre- and postoperative serum prolidase levels were found to be higher in patients with mitral valve insufficiency in Group 2. In conclusion, in this study, it was determined that the plasma prolidase level was higher in patients with mitral valve insufficiency who underwent CABS.
Keywords : İskemik mitral yetmezlik, Kardiyopulmoner baypas, Koroner baypas cerrahisi, Mitral kapak yetmezliği, Prolidaz